Found: 76
Select item for more details and to access through your institution.
Improving Routine <sup>89</sup>Zr‐Immuno‐PET Applications: Mild Iron Removal Can Favor the Use of Fe‐DFO‐N‐suc‐TFP Ester Over p‐NCS‐Bz‐DFO.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2024, v. 67, n. 8, p. 280, doi. 10.1002/jlcr.4097
- By:
- Publication type:
- Article
Natural killer (NK) cells as effectors of antibody-dependent cytotoxicity with chimeric antibodies reactive with human squamous-cell carcinomas of the head and neck.
- Published in:
- International Journal of Cancer, 1995, v. 61, n. 6, p. 864, doi. 10.1002/ijc.2910610620
- By:
- Publication type:
- Article
Anti-tumor and differentiation-inducing activity of n,n-dimethylformamide (dmf) in head-and-neck cancer xenografts.
- Published in:
- International Journal of Cancer, 1989, v. 43, n. 2, p. 285, doi. 10.1002/ijc.2910430221
- By:
- Publication type:
- Article
Advancing <sup>89</sup>Zr-immuno-PET in neuroscience with a bispecific anti-amyloid-beta monoclonal antibody -- The choice of chelator is essential.
- Published in:
- Theranostics, 2022, v. 12, n. 16, p. 7067, doi. 10.7150/thno.73509
- By:
- Publication type:
- Article
The Development of Positron Emission Tomography Tracers for In Vivo Targeting the Kinase Domain of the Epidermal Growth Factor Receptor.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 4, p. N.PAG, doi. 10.3390/ph15040450
- By:
- Publication type:
- Article
The Added Value of Diagnostic and Theranostic PET Imaging for the Treatment of CNS Tumors.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 3, p. 1029, doi. 10.3390/ijms21031029
- By:
- Publication type:
- Article
Good practices for <sup>89</sup>Zr radiopharmaceutical production and quality control.
- Published in:
- EJNMMI Radiopharmacy & Chemistry, 2024, v. 9, n. 1, p. 1, doi. 10.1186/s41181-024-00258-y
- By:
- Publication type:
- Article
Radioimmunotherapy for Indolent B-Cell Non-Hodgkin Lymphoma in Relapsed, Refractory and Transformed Disease.
- Published in:
- BioDrugs, 2006, v. 20, n. 4, p. 201, doi. 10.2165/00063030-200620040-00001
- By:
- Publication type:
- Article
PET‐CT Imaging of Polymeric Nanoparticle Tumor Accumulation in Patients.
- Published in:
- Advanced Materials, 2022, v. 34, n. 21, p. 1, doi. 10.1002/adma.202201043
- By:
- Publication type:
- Article
Immuno-PET: A Navigator in Monoclonal Antibody Development and Applications.
- Published in:
- Oncologist, 2007, v. 12, n. 12, p. 1379, doi. 10.1634/theoncologist.12-12-1379
- By:
- Publication type:
- Article
How to obtain the image-derived blood concentration from <sup>89</sup>Zr-immuno-PET scans.
- Published in:
- EJNMMI Physics, 2024, v. 11, n. 1, p. 1, doi. 10.1186/s40658-024-00621-7
- By:
- Publication type:
- Article
3D Convolutional Neural Network-Based Denoising of Low-Count Whole-Body 18 F-Fluorodeoxyglucose and 89 Zr-Rituximab PET Scans.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 3, p. 596, doi. 10.3390/diagnostics12030596
- By:
- Publication type:
- Article
Platinum(II) as Bifunctional Linker in Antibody-Drug Conjugate Formation: Coupling of a 4-Nitrobenzo-2-oxa-1,3-diazole Fluorophore to Trastuzumab as a Model.
- Published in:
- ChemMedChem, 2015, v. 10, n. 5, p. 797, doi. 10.1002/cmdc.201402496
- By:
- Publication type:
- Article
High dose rhenium-186-labeling of monoclonal antibodies for clinical application.
- Published in:
- Cancer (0008543X), 1997, v. 80, n. S12, p. 2360, doi. 10.1002/(SICI)1097-0142(19971215)80:12+<2360::AID-CNCR5>3.0.CO;2-F
- By:
- Publication type:
- Article
<sup>89</sup>Zr-Labeled High-Density Lipoprotein Nanoparticle PET Imaging Reveals Tumor Uptake in Patients with Esophageal Cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 12, p. 1880, doi. 10.2967/jnumed.121.263330
- By:
- Publication type:
- Article
<sup>89</sup>Zr-labeled High-Density Lipoprotein Nanoparticle PET imaging reveals tumor uptake in patients with esophageal cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263330
- By:
- Publication type:
- Article
<sup>89</sup>Zr-labeled High-Density Lipoprotein Nanoparticle PET imaging reveals tumor uptake in patients with esophageal cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263330
- By:
- Publication type:
- Article
<sup>89</sup>Zr-labeled High-Density Lipoprotein Nanoparticle PET imaging reveals tumor uptake in patients with esophageal cancer.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263330
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262473
- By:
- Publication type:
- Article
First-in-human study of 89Zr-pembrolizumab PET/CT in patients with advanced stage non-smallcell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
PD-L1 PET/CT imaging with radiolabeled durvalumab in patients with advanced stage non-small cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262473
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
First-in-human study of <sup>89</sup>Zr-pembrolizumab PET/CT in patients with advanced stage non-small-cell lung cancer.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.121.261926
- By:
- Publication type:
- Article
The navigating and de-risking role of <sup>89</sup>Zr-immuno-PET in the development of biopharmaceuticals.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.239558
- By:
- Publication type:
- Article
<sup>89</sup>Zr-immuno-PET: towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.224568
- By:
- Publication type:
- Article
Brain Access of Monoclonal Antibodies as Imaged and Quantified by <sup>89</sup>Zr-Antibody PET: Perspectives for Treatment of Brain Diseases.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.220939
- By:
- Publication type:
- Article
Fully Automated <sup>89</sup>Zr Labeling and Purification of Antibodies.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 5, p. 691, doi. 10.2967/jnumed.118.217158
- By:
- Publication type:
- Article
Brain Access of Monoclonal Antibodies as Imaged and Quantified by <sup>89</sup>Zr-Antibody PET: Perspectives for Treatment of Brain Diseases.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 5, p. 615, doi. 10.2967/jnumed.118.220939
- By:
- Publication type:
- Article
In Vivo Characterization of Platinum(II)-Based Linker Technology for the Development of Antibody--Drug Conjugates: Taking Advantage of Dual Labeling with <sup>195m</sup>Pt and <sup>89</sup>Zr.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 7, p. 1146, doi. 10.2967/jnumed.117.206672
- By:
- Publication type:
- Article
PET/CT-Derived Whole-Body and Bone Marrow Dosimetry of <sup>89</sup>Zr-Cetuximab.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 2, p. 249, doi. 10.2967/jnumed.114.147819
- By:
- Publication type:
- Article
Three-Dimensional Histologic Validation of High-Resolution SPECT of Antibody Distributions Within Xenografts.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 5, p. 830, doi. 10.2967/jnumed.113.125401
- By:
- Publication type:
- Article
Multicenter Harmonization of <sup>89</sup>Zr PET/CT Performance.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 2, p. 264, doi. 10.2967/jnumed.113.130112
- By:
- Publication type:
- Article
Pilot Study on the Feasibility of PET/CT Lymphoscintigraphy with <sup>89</sup>Zr-Nanocolloidal Albumin for Sentinel Node Identification in Oral Cancer Patients.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 4, p. 585, doi. 10.2967/jnumed.112.115188
- By:
- Publication type:
- Article
Phase 0 Microdosing PET Study Using the Human Mini Antibody F16SIP in Head and Neck Cancer Patients.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 3, p. 397, doi. 10.2967/jnumed.112.111310
- By:
- Publication type:
- Article
<sup>89</sup>Zr-Nanocolloidal Albumin--Based PET/CT Lymphoscintigraphy for Sentinel Node Detection in Head and Neck Cancer: Preclinical Results.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 10, p. 1580, doi. 10.2967/jnumed.111.089557
- By:
- Publication type:
- Article
PET of Hypoxia with <sup>89</sup>Zr-Labeled cG250-F(ab')<sub>2</sub> in Head and Neck Tumors.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 7, p. 1076, doi. 10.2967/jnumed.109.073189
- By:
- Publication type:
- Article
<sup>89</sup>Zr-Bevacizumab PET of Early Antiangiogenic Tumor Response to Treatment with HSP90 Inhibitor NVP-AUY922.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 5, p. 761, doi. 10.2967/jnumed.109.071043
- By:
- Publication type:
- Article
Radiation Dosimetry of <sup>89</sup>Zr-Labeled Chimeric Monoclonal Antibody U36 as Used for Immuno-PET in Head and Neck Cancer Patients.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 11, p. 1828, doi. 10.2967/jnumed.109.065862
- By:
- Publication type:
- Article
Development and Characterization of Clinical-Grade <sup>89</sup>Zr-Trastuzumab for HER2/neu ImmunoPET Imaging.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 6, p. 974, doi. 10.2967/jnumed.108.060392
- By:
- Publication type:
- Article
Disparity Between In Vivo EGFR Expression and <sup> 89</sup>Zr-Labeled Cetuximab Uptake Assessed with PET.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 1, p. 123, doi. 10.2967/jnumed.108.054312
- By:
- Publication type:
- Article
Validation of simplified uptake measures against dynamic Patlak K<sub>i</sub> for quantification of lesional <sup>89</sup>Zr-Immuno-PET antibody uptake.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 7, p. 1897, doi. 10.1007/s00259-023-06151-1
- By:
- Publication type:
- Article
Head-to-head comparison of DFO* and DFO chelators: selection of the best candidate for clinical 89Zr-immuno-PET.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 3, p. 694, doi. 10.1007/s00259-020-05002-7
- By:
- Publication type:
- Article
Interobserver reproducibility of tumor uptake quantification with <sup>89</sup>Zr-immuno-PET: a multicenter analysis.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 9, p. 1840, doi. 10.1007/s00259-019-04377-6
- By:
- Publication type:
- Article
Synthesis and preclinical evaluation of [<sup>11</sup>C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor.
- Published in:
- EJNMMI Research, 2024, v. 14, p. 1, doi. 10.1186/s13550-024-01078-6
- By:
- Publication type:
- Article
Non-specific irreversible <sup>89</sup>Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using <sup>89</sup>Zr-immuno-PET.
- Published in:
- EJNMMI Research, 2024, v. 14, p. 1, doi. 10.1186/s13550-024-01079-5
- By:
- Publication type:
- Article
Potential and pitfalls of <sup>89</sup>Zr-immuno-PET to assess target status: <sup>89</sup>Zr-trastuzumab as an example.
- Published in:
- EJNMMI Research, 2021, v. 11, n. 1, p. 1, doi. 10.1186/s13550-021-00813-7
- By:
- Publication type:
- Article
Pharmacokinetics, Brain Delivery, and Efficacy in Brain Tumor-Bearing Mice of Glutathione Pegylated Liposomal Doxorubicin (2B3-101).
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0082331
- By:
- Publication type:
- Article
A panel of biomarkers of carcinogenesis of the upper aerodigestive tract as potential intermediate endpoints in chemoprevention trials.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Perspectives of combined radioimmunotherapy and anti-EGFR antibody therapy for the treatment of residual head and neck cancer.
- Published in:
- International Journal of Cancer, 1998, v. 77, n. 1, p. 13, doi. 10.1002/(SICI)1097-0215(19980703)77:1<13::AID-IJC3>3.0.CO;2-2
- By:
- Publication type:
- Article